GB-1265

N/A

Report date: 2025/01/26 19:02:24
NME

Base Information

Drug NameGB-1265
Drug Alias NameGB-1265
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsCorneal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGalecto Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesGalecto Biotech AB
Inactive CompaniesN/A
Active IndicationsCorneal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A